Eisai Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 1, 2026; Provides Dividend Guidance for Second Quarter- End and Fiscal Year Ending March 31, 2027
Eisai Co., Ltd. announced dividend for the Fiscal Year Ended March 31, 2026 and Provided Dividend Guidance for Second Quarter- End and Fiscal Year Ending March 31, 2027. For the Fiscal Year Ended March 31, 2026, the company announced dividend of JPY 80.00 per share compared to JPY 80.00 per share a year ago. Expected date of ordinary general meeting of shareholders: June 17, 2026, Expected date of dividend payment commencement: June 1, 2026.
For the second quarter- end, the company expects dividend of JPY 80.00 per share compared to JPY 80.00 per share a year ago.
For the Fiscal Year- end, the company expects dividend of JPY 80.00 per share compared to JPY 80.00 per share a year ago.
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Eisai Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 1, 2026; Provides Dividend Guidance for Second Quarter- End and Fiscal Year Ending March 31, 2027
Choose MarketScreener 
